ArticleTranslational cancer research2019
The effect of hericium polysaccharides combined with aspirin on the expression of CD133 and ABCG2 in lung cancer.
Article in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- Lentinan inhibits colorectal cancer stemness by binding CD133 and suppressing the CD133/p85/p-AKT signaling axis.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe study was designed to investigate the effects of aspirin and hericium polysaccharides (HP) on the expression of CD133 and ABCG2 in lung cancer growth.
methods
resultsAspirin alone, HP alone and combined aspirin and HP inhibited cell proliferation significantly. Western blot results showed that Aspirin alone, HP alone and combined HP and aspirin inhibited the expression levels of CD133 significantly, but HP alone did not inhibit the expression levels of ABCG2. Combined HP and aspirin are synergistic.
conclusionsThe combined effect of aspirin and HP inhibited tumor growth significantly by obstructing CD133 and ABCG2 expression in lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.